Skip to main content
OpenTrials

Clinical trial condition

NSCLC Patients With EGFR Activating Mutation

Explore clinical trials studying NSCLC Patients With EGFR Activating Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

NSCLC Patients With EGFR Activating Mutation trial results

Recruiting

First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

NCT07755397

Conditions
Adenoid Cystic Carcinoma Metastatic, Adenoid Cystic Carcinoma of the Head and Neck, NSCLC Patients With EGFR Activating Mutation
Locations
  • Kiran Super Multi-Speciality Hospital Surat, Gujarat, India
  • Oncoville Cancer Hospital and Research Center Bangalore, Karnataka, India
  • Tata Memorial Center Mumbai, Maharashtra, India
  • HCG Manavata Cancer Centre Nashik, Maharashtra, India
View Trial Details

Related conditions